In This Section      

Pharmacy Residency Program: Oncology

General Information

Program Type: ASHP-Accredited PGY2 Oncology 
ASHP Match Number: 537860

NOTE:   There will be three positions for the 2019-2020 residency year. Two of these positions have been filled, leaving one available position.

Purpose Statement:

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program Overview:

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is one of approximately 40 cancer centers in the United States designated by the National Cancer Institute (NCI) as a comprehensive cancer center. With the exception of the pediatric population, who has their own facility, oncology patients seen at the Cancer Center receive their care in the Weinberg Building. An oncology pharmacy satellite within this building provides pharmaceutical care for over 80 inpatient oncology beds dedicated to Medical Oncology, Hematology and Bone Marrow Transplantation services, an outpatient oncology clinic where over 120 doses of chemotherapy are administered each day, and an oncology investigational drug service that supports approximately 350 active oncology clinical trials. 

Over the course of a year the resident will become comfortable recognizing and managing cancer- and treatment-related complications, such as pain, infection, alterations in fluids/electrolytes/nutrition, hematologic toxicities and gastrointestinal toxicities. Emphasis will be placed on gaining knowledge and skills to manage and provide recommendations for antineoplastics including chemotherapy and immunotherapy. Residents will gain hands-on experience with oncology clinical decision support and oncology pharmacy administration and will be involved in different aspects of clinical research. Upon completion of this residency training, the resident will have developed the clinical skills necessary to practice as an oncology clinical specialist

Training Experience:

  • Management of a diverse group of solid and hematologic malignancies in the acute care
    and ambulatory settings.
  • Familiarity with investigational cancer treatments as well as standard of care
  • Multidisciplinary patient care rounds
  • Patient and caregiver education
  • Multidisciplinary conferences including: Oncology Grand Rounds, Oncology Journal Club, Oncology Pain Conference, and disease-specific case conferences
  • Teaching opportunities within the cancer center, Department of Pharmacy, as well as the University of Maryland School of Pharmacy 

Rotations: Ten months are devoted to orientation and core experiences; two months are available for electives. Residents will also participate longitudinally in an oncology anticoagulation clinic, oncology clinical decision support, and oncology pharmacy administration. 

two medical professionals speaking with a patient in a hospital bed

Core Experiences:

  • Inpatient Medical Oncology
  • Inpatient Hematologic Malignancies  
  • Inpatient Myeloma, Lymphoma and Bone Marrow Transplant
  • Ambulatory oncology clinics including Hematologic Malignancies, Multiple Myeloma, Breast, Melanoma, Thoracic, Gastrointestinal, Genitourinary, and Central Nervous System Malignancies  
  • Pain and Palliative Care
  • Longitudinal Oncology Practice Administration 
  • Longitudinal Investigational Drug Service 
  • Longitudinal Oncology Clinical Decision Support 
  • Longitudinal Oncology Anticoagulation Clinic

Additional Opportunities:

  • Immunocompromised Infectious Disease
  • Pediatric Oncology 



Benefits: Click Here
Staffing: Click Here
On-Call: Click Here
Application Information: 
All applications will be accepted through PHORCAS: Click Here

Program Director


Amy Bryk, Pharm.D., BCOP, BCPS

Title: Clinical Pharmacy Specialist/Clinical Pharmacy Practitioner, Blood and Marrow Transplantation
Education: Doctor of Pharmacy, University of North Carolina at Chapel Hill
Training: Pharmacy Practice Residency - Virginia Commonwealth University Health System
Oncology Specialty Residency - The Johns Hopkins Hospital

Dr. Bryk is a clinical pharmacy practitioner with the blood and marrow transplantation service at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital.  She is also the Director of the PGY-2 Oncology Residency Program at Johns Hopkins and serves as an Assistant Clinical Professor at the University of Maryland School of Pharmacy. Dr. Bryk’s practice areas including bone marrow transplantation, lymphoma and multiple myeloma.   Her passion and talent for teaching is reflected in her recognition as the 2015-2016 Notre Dame of Maryland University APPE Preceptor of the Year.

Dr. Bryk is has published and presented nationally and regionally on topics within her clinical expertise.  She is a member and actively involved in the Hematology Oncology Pharmacists Association and the American Society for Blood and Marrow Transplantation.


Amy Bryk, Pharm.D., BCOP, BCPS
Clinical Pharmacy Specialist/Clinical Pharmacy Practitioner, Blood and Marrow Transplantation
Program Director, PGY2 Oncology Residency
The Johns Hopkins Hospital
Location: The Johns Hopkins Hospital
600 North Wolfe Street/Carnegie 180
Baltimore, MD 21287
Phone: 443-287-5193